Impact of the EMA/FDA alerts on the use of effective contraceptive method in women of childbearing age undergoing valproic acid treatment in a long-stay psychiatric center-Reference-Cited by-同舟云学术

Impact of the EMA/FDA alerts on the use of effective contraceptive method in women of childbearing age undergoing valproic acid treatment in a long-stay psychiatric center

Published:2020-06 Issue: Volume:107 Page:107072
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Puig-Molto María,Pol-Yanguas Emilio,Segarra Lidia,Lumbreras Blanca^ORCID

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Clinical Neurology,Neurology

Reference13 articles.

1. Use of valproic acid in long stay units of psychiatry;Martínez-Lazcano;Farm Hosp,2015

2. Teratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy;Langan;BMC Psychiatry,2013

3. Abbott pays $1.6bn for promoting off label use of valproic acid;Roehr;BMJ,2012

4. Ten common questions (and their answers) about off-label drug use;Wittich;Mayo Clin Proc,2012

5. Teratogenic potential of valproic acid;Brown;Lancet.,1980

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effekt der Rote-Hand-Briefe zu Citalopram und Escitalopram auf Verordnungszahlen bei der stationären Behandlung von Angsterkrankungen;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2022-09-28

2. Drug-drug interactions between psychotropic medications and oral contraceptives;Expert Opinion on Drug Metabolism & Toxicology;2022-06-03

3. Valproate Restrictions in Sweden and Norway: Online survey suggests implementation deficit;Acta Neurologica Scandinavica;2022-01-07

4. Eficacia de las medidas de minimización de riesgos del ácido valproico: estudio de utilización del fármaco en Europa, análisis de datos de España;Revista de Neurología;2021